Male Breast Cancer: Case Series in a Philippine Tertiary Care Hospital

Author(s) :

Jose Ma. H. Zaldarriaga1, Julius Cezar P. Rojales1, Kathleen Jane U. Cortez1, Janet M. Martinez1, Gaudencio P. Vega1

1Department of Radiation Oncology, St. Luke’s Medical Center, Republic of the Philippines

Corresponding author: Jose Ma. H. Zaldarriaga, Email:

Published: Volume IV, Issue 1, 1 May 2024, -



May 1, 2024 0 Comments


Male breast cancer (MBC) is a rare disease with potentially distinct biological and clinical differences compared to its more common female counterpart. It accounts for less than 1% of all breast cancer cases, less than 1% of all male cancers, and less than 0.1% of all cancer deaths in men.

This is a case series of seven elderly gentlemen diagnosed with MBC. All patients underwent trimodality treatment of neoadjuvant chemotherapy, followed by mastectomy, capped by radiation therapy and adjuvant tamoxifen. The cases are juxtaposed and integrated with the current literature on male breast cancer.

Notify of
Inline Feedbacks
View all comments